Suppression of Fas ligand expression on endothelial cells by arsenite through reactive oxygen species

Toxicology Letters

Volumn 123, Issue 1, 2001, Pages 11-19

  Tsai, Shu Huei ^a   Hsieh, Ming Shium ^a   Chen, Linda ^b   Liang, Yu Chih ^a   Lin, Jen Kun ^b   Lin, Shyr Yi ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arsenite; ECV304; Fas ligand; Reactive oxygen species (ROS)

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ARSENIC TRIOXIDE; FAS ANTIBODY; HYDROGEN PEROXIDE; LIGAND; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENDOTHELIUM LESION; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCYSTEINE; ARSENITES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FAS LIGAND PROTEIN; HUMANS; MEMBRANE GLYCOPROTEINS; PEROXIDES; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035817151     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00373-3     Document Type: Article

References (32)

1. Arsenic induces oxidant stress and NFκB activation in cultured aortic endothelial cells
2. Role of reactive oxygen intermediates in activation-induced CD95 (Apo-1/Fas) ligand expression
3. A role for CD95 ligand in preventing graft rejection
4. Arsenic
5. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water
6. Increased prevalence of hypertension and long-term arsenic exposure
7. Atherogenicity and carcinogenecity of high-arsenic artesian well water: Multiple risk factors and related malignant neoplasms of blackfoot disease
8. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis
9. Arsenic in drinking water and mortality from vascular disease: An ecological analysis in 30 countries in the United States
10. Vascular effects of chronic arsenic exposure: A review
11. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
12. Fas ligand-induced apoptosis as a mechanism of immune privilege
13. Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction
14. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
15. Role of free radicals and catalytic metal ions in human disease: An overview
16. Ingested inorganic arsenic and prevalence of diabetes mellitus
17. Prevention of islet allograft rejection with engineered myoblasts expression FasL in mice
18. Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide
19. The Fas death factor
20. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia
21. Physiological and molecular mechanisms of lymphocyte homing
22. Tumor necrosis factor-alpha induces the phosphorylation of 28 kDa stress proteins in endothelial cells: Possible role in protection against cytotoxicity?
23. The pathogenesis of atherosclerosis: A perspective for the 1990s
24. TNFα regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravassion
25. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response
26. Cytotixic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions
27. Depletion of the motochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF
28. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration
29. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (Apo-1/Fas) mediated apoptosis
30. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan
31. Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO-1/Fas) ligand expression in microglial cells
32. Negative regulation of inflammatory by fas ligand expression on the vasular endothelium